These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
557 related items for PubMed ID: 24119645
1. A xeno-free culture method that enhances Wharton's jelly mesenchymal stromal cell culture efficiency over traditional animal serum-supplemented cultures. Julavijitphong S, Wichitwiengrat S, Tirawanchai N, Ruangvutilert P, Vantanasiri C, Phermthai T. Cytotherapy; 2014 May; 16(5):683-91. PubMed ID: 24119645 [Abstract] [Full Text] [Related]
2. Stage-specific embryonic antigen 4 in Wharton's jelly-derived mesenchymal stem cells is not a marker for proliferation and multipotency. He H, Nagamura-Inoue T, Tsunoda H, Yuzawa M, Yamamoto Y, Yorozu P, Agata H, Tojo A. Tissue Eng Part A; 2014 Apr; 20(7-8):1314-24. PubMed ID: 24279891 [Abstract] [Full Text] [Related]
3. Wharton's jelly mesenchymal stromal/stem cells derived under chemically defined animal product-free low oxygen conditions are rich in MSCA-1(+) subpopulation. Devito L, Badraiq H, Galleu A, Taheem DK, Codognotto S, Siow R, Khalaf Y, Briley A, Shennan A, Poston L, McGrath J, Gentleman E, Dazzi F, Ilic D. Regen Med; 2014 Apr; 9(6):723-32. PubMed ID: 25431909 [Abstract] [Full Text] [Related]
6. Human umbilical cord Wharton's jelly-derived mesenchymal stem cells differentiate into a Schwann-cell phenotype and promote neurite outgrowth in vitro. Peng J, Wang Y, Zhang L, Zhao B, Zhao Z, Chen J, Guo Q, Liu S, Sui X, Xu W, Lu S. Brain Res Bull; 2011 Feb 28; 84(3):235-43. PubMed ID: 21194558 [Abstract] [Full Text] [Related]
7. A simple and serum-free protocol for cryopreservation of human umbilical cord as source of Wharton's jelly mesenchymal stem cells. Roy S, Arora S, Kumari P, Ta M. Cryobiology; 2014 Jun 28; 68(3):467-72. PubMed ID: 24704519 [Abstract] [Full Text] [Related]
8. Are serum-free and xeno-free culture conditions ideal for large scale clinical grade expansion of Wharton's jelly derived mesenchymal stem cells? A comparative study. Swamynathan P, Venugopal P, Kannan S, Thej C, Kolkundar U, Bhagwat S, Ta M, Majumdar AS, Balasubramanian S. Stem Cell Res Ther; 2014 Jul 28; 5(4):88. PubMed ID: 25069491 [Abstract] [Full Text] [Related]
10. Positive selection of Wharton's jelly-derived CD105(+) cells by MACS technique and their subsequent cultivation under suspension culture condition: A simple, versatile culturing method to enhance the multipotentiality of mesenchymal stem cells. Amiri F, Halabian R, Dehgan Harati M, Bahadori M, Mehdipour A, Mohammadi Roushandeh A, Habibi Roudkenar M. Hematology; 2015 May 28; 20(4):208-16. PubMed ID: 25116042 [Abstract] [Full Text] [Related]
11. Carcinogenicity, efficiency and biosafety analysis in xeno-free human amniotic stem cells for regenerative medical therapies. Phermthai T, Thongbopit S, Pokathikorn P, Wichitwiengrat S, Julavijitphong S, Tirawanchai N. Cytotherapy; 2017 Aug 28; 19(8):990-1001. PubMed ID: 28566211 [Abstract] [Full Text] [Related]
12. Mitochondrial transfer from Wharton's jelly-derived mesenchymal stem cells to mitochondria-defective cells recaptures impaired mitochondrial function. Lin HY, Liou CW, Chen SD, Hsu TY, Chuang JH, Wang PW, Huang ST, Tiao MM, Chen JB, Lin TK, Chuang YC. Mitochondrion; 2015 May 28; 22():31-44. PubMed ID: 25746175 [Abstract] [Full Text] [Related]
14. Isolation of a novel embryonic stem cell cord blood-derived population with in vitro hematopoietic capacity in the presence of Wharton's jelly-derived mesenchymal stromal cells. Gounari E, Daniilidis A, Tsagias N, Michopoulou A, Kouzi K, Koliakos G. Cytotherapy; 2019 Feb 28; 21(2):246-259. PubMed ID: 30522805 [Abstract] [Full Text] [Related]
15. Isolation and characterization of Wharton's jelly-derived multipotent mesenchymal stromal cells obtained from bovine umbilical cord and maintained in a defined serum-free three-dimensional system. Cardoso TC, Ferrari HF, Garcia AF, Novais JB, Silva-Frade C, Ferrarezi MC, Andrade AL, Gameiro R. BMC Biotechnol; 2012 May 04; 12():18. PubMed ID: 22559872 [Abstract] [Full Text] [Related]
16. Immunomodulatory effects of human umbilical cord Wharton's jelly-derived mesenchymal stem cells on differentiation, maturation and endocytosis of monocyte-derived dendritic cells. Saeidi M, Masoud A, Shakiba Y, Hadjati J, Mohyeddin Bonab M, Nicknam MH, Latifpour M, Nikbin B. Iran J Allergy Asthma Immunol; 2013 Mar 04; 12(1):37-49. PubMed ID: 23454777 [Abstract] [Full Text] [Related]
17. Human Wharton's jelly mesenchymal stem cell secretome display antiproliferative effect on leukemia cell line and produce additive cytotoxic effect in combination with doxorubicin. Hendijani F, Javanmard SH, Sadeghi-aliabadi H. Tissue Cell; 2015 Jun 04; 47(3):229-34. PubMed ID: 25779671 [Abstract] [Full Text] [Related]
18. DMSO- and Serum-Free Cryopreservation of Wharton's Jelly Tissue Isolated From Human Umbilical Cord. Shivakumar SB, Bharti D, Subbarao RB, Jang SJ, Park JS, Ullah I, Park JK, Byun JH, Park BW, Rho GJ. J Cell Biochem; 2016 Oct 04; 117(10):2397-412. PubMed ID: 27038129 [Abstract] [Full Text] [Related]
19. The effect of fibroblast growth factor on distinct differentiation potential of cord blood-derived unrestricted somatic stem cells and Wharton's jelly-derived mesenchymal stem/stromal cells. Lee S, Park BJ, Kim JY, Jekarl D, Choi HY, Lee SY, Kim M, Kim Y, Park MS. Cytotherapy; 2015 Dec 04; 17(12):1723-31. PubMed ID: 26589753 [Abstract] [Full Text] [Related]
20. Wharton's jelly mesenchymal stromal cells have contrasting effects on proliferation and phenotype of cancer stem cells from different subtypes of lung cancer. Vulcano F, Milazzo L, Ciccarelli C, Eramo A, Sette G, Mauro A, Macioce G, Martinelli A, La Torre R, Casalbore P, Hassan HJ, Giampaolo A. Exp Cell Res; 2016 Jul 15; 345(2):190-8. PubMed ID: 27343631 [Abstract] [Full Text] [Related] Page: [Next] [New Search]